Company Filing History:
Years Active: 1997
Title: Jan Stenhede: Innovator in Pharmaceutical Synthesis
Introduction
Jan Stenhede is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceutical synthesis, particularly through his innovative methods. His work has led to advancements in the synthesis of important compounds used in medical treatments.
Latest Patents
Jan Stenhede holds a patent for a method for the synthesis of trisodium phosphonoformate hexahydrate, commonly known as foscarnet. The patent outlines a detailed process that includes adding sodium hydroxide to water, heating the solution, and incorporating triethyl phosphonoformate. The reaction mixture is then heated to reflux for about one hour, followed by cooling and filtering to obtain the final product. This method is crucial for the production of foscarnet, which is used in antiviral therapies.
Career Highlights
Jan Stenhede is associated with Aktiebolaget Astra, a prominent company in the pharmaceutical industry. His role at the company has allowed him to focus on innovative research and development in drug synthesis. His expertise and dedication have contributed to the advancement of pharmaceutical sciences.
Collaborations
Jan has worked alongside Edib Jakupovic, collaborating on various projects that aim to enhance pharmaceutical processes and product development.
Conclusion
Jan Stenhede's contributions to the field of pharmaceutical synthesis, particularly through his patented method for synthesizing foscarnet, highlight his innovative spirit and commitment to advancing medical science. His work continues to impact the pharmaceutical industry positively.